Linobo, Rosita D.

HRN: 27-22-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/08/2025
IV
2g
OD
Tbi Severe
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines